TipRanks
Escalon Medical (ESMC)
OTHER OTC:ESMC
US Market
ESMC
Escalon Medical
RESEARCH TOOLSreports

Escalon Medical (ESMC) Ratios

12 Followers

Escalon Medical Ratios

ESMC's free cash flow for Q3 2026 was $0.36. For the 2026 fiscal year, ESMC's free cash flow was decreased by $ and operating cash flow was $-0.16. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
 2.59 1.72 1.65 1.63 1.39
Quick Ratio
 -651.94 -796.07 1.04 1.07 0.86
Cash Ratio
 1.32K 203.27 0.08 0.31 0.20
Solvency Ratio
 0.56 0.05 -0.03 0.15 0.09
Operating Cash Flow Ratio
 110.78 0.14 -0.23 0.11 -0.35
Short-Term Operating Cash Flow Coverage
 80.95K 8.64 -16.14 8.09 -5.05
Net Current Asset Value
$ 3.18M$ 1.53M$ 1.45M$ 1.26M$ 491.56K
Leverage Ratios
Debt-to-Assets Ratio
 0.13 0.10 0.11 0.17 0.23
Debt-to-Equity Ratio
 0.24 0.27 0.29 0.46 0.82
Debt-to-Capital Ratio
 0.20 0.21 0.22 0.32 0.45
Long-Term Debt-to-Capital Ratio
 0.03 0.11 0.13 0.14 0.09
Financial Leverage Ratio
 1.82 2.61 2.63 2.74 3.50
Debt Service Coverage Ratio
 -45.60 <0.01 -1.01 8.46 1.61
Interest Coverage Ratio
 -55.03 <0.01 -5.03 22.04 1.98
Debt to Market Cap
 0.12 0.11 0.29 0.19 0.39
Interest Debt Per Share
 0.14 3.13 0.07 0.12 0.16
Net Debt to EBITDA
 3.71K -3.28K -5.40 <0.01 1.68
Profitability Margins
Gross Profit Margin
41.48%45.75%42.95%45.00%43.04%
EBIT Margin
-8.11%1.06%-0.87%3.93%0.34%
EBITDA Margin
-7.86%1.38%-0.49%4.30%3.41%
Operating Profit Margin
-7.82%1.11%-0.87%3.93%0.34%
Pretax Profit Margin
16.18%0.88%-1.05%3.75%0.17%
Net Profit Margin
16.18%0.88%-1.05%3.75%0.17%
Continuous Operations Profit Margin
16.18%0.88%-1.05%3.75%0.17%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
-206.86%79.21%119.89%95.46%49.55%
Return on Assets (ROA)
24.58%2.11%-2.63%8.61%0.35%
Return on Equity (ROE)
77.88%5.51%-6.92%23.61%1.22%
Return on Capital Employed (ROCE)
-17.90%5.77%-5.00%19.49%1.68%
Return on Invested Capital (ROIC)
-17.36%5.46%-4.48%16.94%1.36%
Return on Tangible Assets
24.61%2.13%-2.66%8.72%0.36%
Earnings Yield
161.09%4.40%-11.85%24.64%1.93%
Efficiency Ratios
Receivables Turnover
 8.53 <0.01 5.64 7.37 6.94
Payables Turnover
 7.47 <0.01 5.04 5.56 6.02
Inventory Turnover
 <0.01 <0.01 4.24 4.22 3.80
Fixed Asset Turnover
 0.01 0.04 48.14 22.65 12.73
Asset Turnover
 1.52 2.41 2.52 2.29 2.07
Working Capital Turnover Ratio
 4.00 6.59 6.82 8.21 9.00
Cash Conversion Cycle
 90.33K 92.69K 78.37 70.40 87.99
Days of Sales Outstanding
 42.78 50.52K 64.71 49.56 52.58
Days of Inventory Outstanding
 90.33K 119.65K 86.14 86.52 96.03
Days of Payables Outstanding
 48.89 77.48K 72.47 65.68 60.62
Operating Cycle
 90.38K 170.17K 150.85 136.08 148.61
Cash Flow Ratios
Operating Cash Flow Per Share
 37.84 0.05 -0.08 0.04 -0.14
Free Cash Flow Per Share
 37.84 0.05 -0.09 0.04 -0.14
CapEx Per Share
 <0.01 0.00 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.07 0.96 1.00
Dividend Paid and CapEx Coverage Ratio
 72.31K 0.00 -14.96 23.49 0.00
Capital Expenditure Coverage Ratio
 72.31K 0.00 -14.96 23.49 0.00
Operating Cash Flow Coverage Ratio
 277.63 0.73 -1.15 0.37 -0.87
Operating Cash Flow to Sales Ratio
 24.51 0.03 -0.05 0.03 -0.10
Free Cash Flow Yield
24410.37%15.86%-60.86%16.79%-111.88%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 1.43 85.19 -8.44 4.06 51.90
Price-to-Sales (P/S) Ratio
 0.10 0.20 0.09 0.15 0.09
Price-to-Book (P/B) Ratio
 0.28 1.25 0.58 0.96 0.63
Price-to-Free Cash Flow (P/FCF) Ratio
 <0.01 6.31 -1.64 5.96 -0.89
Price-to-Operating Cash Flow Ratio
 <0.01 6.31 -1.75 5.70 -0.89
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 -0.74 0.06 <0.01 -0.42
Price-to-Fair Value
 0.28 1.25 0.58 0.96 0.63
Enterprise Value Multiple
 3.71K -3.27K -23.47 3.54 4.25
Enterprise Value
 -3.34B -542.91M 1.37M 1.85M 1.55M
EV to EBITDA
 3.71K -3.27K -23.47 3.54 4.25
EV to Sales
 -291.85 -45.07 0.11 0.15 0.14
EV to Free Cash Flow
 -11.91 -1.43K -2.13 5.96 -1.48
EV to Operating Cash Flow
 -11.91 -1.43K -2.28 5.70 -1.48
Tangible Book Value Per Share
 0.56 0.25 0.24 0.25 0.19
Shareholders’ Equity Per Share
 0.56 0.26 0.24 0.26 0.20
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 1.54 1.62 1.62 1.64 1.44
Net Income Per Share
 0.25 0.01 -0.02 0.06 <0.01
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 -2.00 0.82 1.20 0.95 0.50
Research & Development to Revenue
 14.12 62.52 0.06 0.07 0.09
SG&A to Revenue
 232.80 383.92 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.12 3.61 4.81 0.71 -58.07
Currency in USD